| Literature DB >> 17940204 |
Lisa J Russell1, Takashi Akasaka, Aneela Majid, Kei-Ji Sugimoto, E Loraine Karran, Inga Nagel, Lana Harder, Alexander Claviez, Stefan Gesk, Anthony V Moorman, Fiona Ross, Helen Mazzullo, Jonathan C Strefford, Reiner Siebert, Martin J S Dyer, Christine J Harrison.
Abstract
Translocations involving the immunoglobulin heavy chain locus (IGH@) at chromosome band 14q32 are common in mature B-cell neoplasms, but are rare in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Here, we report the translocation, t(6;14)(p22;q32), involving IGH@ as a novel recurrent translocation in 13 BCP-ALL patients. Fluorescence in situ hybridization and long-distance inverse polymerase chain reaction (PCR) identified ID4 as the partner gene. Breakpoints were scattered over a 19kb region centromeric of ID4. Quantitative real-time PCR showed up-regulation of ID4 mRNA. All patients had deletions of CDKN2A and PAX5 located on the short arm of chromosome 9, frequently as a result of an isochromosome, i(9)(q10) (9/13, 69%). This study defines a new subgroup of BCP-ALL characterized by ID4 over-expression and CDKN2A and PAX5 deletions. Preliminary survival data suggest that this subgroup may be associated with a good response to therapy.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17940204 DOI: 10.1182/blood-2007-07-092015
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113